Leftagraph

Every financial statement,
one clean chart.

Search any US-listed company. Data straight from SEC filings.

PROBuild your own list with the screener

IN8BIO, INC. (INAB) financial statements

Number look wrong? Tell us

Data table
PROBuild your own list with the screener

IN8BIO, INC. (INAB), most recent 12 months reported: net loss $18.67M. Latest balance sheet on file: liquid cash $17.96M. From SEC filings. Others in Biological Products, (No Diagnostic Substances): GREEN PLANET BIOENGINEERING CO., LTD. · GREENLAND MINES LTD · Inhibikase Therapeutics, Inc. · IMMUNOVANT, INC. · MiNK Therapeutics, Inc. · INTENSITY THERAPEUTICS, INC. · Quince Therapeutics, Inc. · Jasper Therapeutics, Inc.

Stock screener

Watchlist